“Advancements in Interventional Cardiology”
The balloon-expandable stents market is witnessing steady growth due to the rising prevalence of cardiovascular diseases and advancements in interventional cardiology. Balloon-expandable stents are preferred for their precision, high radial strength, and ability to restore blood flow effectively during angioplasty procedures. Innovations such as drug-eluting stents (DES) are a key market driver, as they release medications to prevent restenosis, enhancing long-term outcomes. A notable trend is the increasing adoption of bioresorbable balloon-expandable stents, which dissolve over time, reducing long-term complications associated with permanent implants. The market is further driven by a growing geriatric population, lifestyle-related risk factors, and the demand for minimally invasive treatments. These factors collectively support the expansion of the balloon-expandable stents market, making it a vital segment in cardiovascular care.
